Table 1.
Showing patient, tumor and treatment characteristics.
| Total no. of patients (60) | Number of patients (%) | |
|---|---|---|
| Sex: | Male | 45 (75) |
| Female | 15 (25) | |
| Age: (Mean 55 years) | 31–40 | 7 (11.66) |
| 41–50 | 17 (28.33) | |
| 51–60 | 15 (25) | |
| 61–70 | 16 (26.66) | |
| 71–80 | 4 (6.66) | |
| 81–94 | 1 (1.66) | |
| Sub-sites: | Oral cavity | 16 (26.66) |
| Oropharynx | 13 (21.66) | |
| Hypopharynx | 20 (33.33) | |
| Larynx | 9 (15) | |
| Nasal Cavity | 1 (1.66) | |
| PNS | 1 (1.66) | |
| Stage: | II | 9 (15) |
| III | 22 (36.66) | |
| IVA | 28 (46.66) | |
| IV B | 1 (1.66) | |
| Comorbidities | Yes | 47 (78.33) |
| No | 13 (21.66) | |
| Surgery | Yes | 20 (33.33) |
| No | 40 (66.66) | |
| Technique | IMRT | 50 (83.33) |
| 3DCRT | 10 (16.66) | |
| Chemo drug | No chemo | 14 (22.33) |
| Cisplatin | 41 (68.33) | |
| Carboplatin | 2 (3.33) | |
| Cis + 5Fu | 1 (1.66) | |
| Cis + carbo | 2 (3.33) | |
| No of chemo cycles (46) | 2 cycles | 2 (3.33) |
| 3 cycles | 5 (8.33) | |
| 4 cycles | 14 (23.33) | |
| 5 cycles | 25 (41.66) | |